Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens

Iran J Med Sci. 2021 Jul;46(4):235-236. doi: 10.30476/ijms.2021.47666.

Author

Manica Negahdaripour^{1

2}

Affiliations

¹ Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
² Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

No abstract available

Publication types

Editorial

MeSH terms

Adenosine Monophosphate / adverse effects
Adenosine Monophosphate / analogs & derivatives
Adenosine Monophosphate / therapeutic use
Blood Glucose
COVID-19 / complications*
COVID-19 Drug Treatment
Humans
Hyperglycemia / therapy*
Hyperglycemia / virology

Substances

Blood Glucose
GS-441524 monophosphate
Adenosine Monophosphate